R.A. Session II's Net Worth
R.A. Session II's net worth is estimated to be at least $803,368.03 as of 05/22/2024. CoreStreet's estimation of R.A. Session II's net worth is based on their sale of stock and current holding of stock.
R.A. Session II is Major Shareholder at Taysha Gene Therapies Inc. They have executed at least 4 trades of stock as per SEC Form 4 filings. Their most recent trade was for 80,528 units of TSHA stock on 07/12/2023. Their biggest sale was on 06/20/2023 when they sold 295,653 units of Taysha Gene Therapies Inc stock for $209,913.63. They typically trade 2 times per year.
Total value of insider buys:
- $528,923.92
Total value of insider sells:
- $274,444.11
Most recent insider trade:
- July 12, 2023
R.A. Session II's Insider Trading History
| Taysha Gene Therapies Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
July 12, 2023 | Major Shareholder | 80,528 | $0.71 | Sell | $57,174.88 |
June 22, 2023 | Major Shareholder | 10,508 | $0.70 | Sell | $7,355.60 |
June 20, 2023 | Major Shareholder | 295,653 | $0.71 | Sell | $209,913.63 |
Nov. 23, 2021 | CEO | 42,518 | $12.44 | Buy | $528,923.92 |